Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 2 | -5.70 | 239.2890 | 0.839 | 0.94037 | 0.83028 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 3 | -6.52 | 286.1860 | 0.876 | 0.88410 | 0.86523 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 4 | -6.12 | 272.4815 | 0.907 | 0.92963 | 0.88889 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 5 | -6.31 | 302.5813 | 0.872 | 0.90672 | 0.84816 | ||||||
| HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 6 | -5.73 | 240.3203 | 0.808 | 0.91922 | 0.84401 | ||||||
| HeLa ICRP | Apomab | 50.0 | nM | anti-Fc | 50.0 | nM | 1 | -5.50 | 240.5143 | 0.794 | 0.93143 | 0.81143 | ||||||
| HeLa ICRP | Apomab | 50.0 | nM | anti-Fc | 50.0 | nM | 2 | -5.58 | 216.2613 | 0.820 | 0.96396 | 0.81532 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 1 | -5.59 | 246.1950 | 0.843 | 0.91195 | 0.75472 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 2 | -5.57 | 204.0816 | 0.810 | 0.89116 | 0.78231 | ||||||
| HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 3 | -5.67 | 243.5165 | 0.863 | 0.94505 | 0.84066 | ||||||
| HeLa ICRP | Apomab | 200.0 | nM | anti-Fc | 200.0 | nM | 1 | -5.73 | 280.2000 | 0.794 | 0.92571 | 0.84000 | ||||||
| HeLa ICRP | Apomab | 200.0 | nM | anti-Fc | 200.0 | nM | 2 | -5.80 | 251.2577 | 0.896 | 0.95706 | 0.87730 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 1 | -6.20 | 481.7639 | 0.801 | 0.96817 | 0.78780 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 2 | -5.39 | 331.3306 | 0.083 | 0.86694 | 0.49064 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 3 | -6.35 | 445.1084 | 0.889 | 0.98103 | 0.88889 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 4 | -6.21 | 485.6552 | 0.814 | 0.97069 | 0.80517 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | nM | 5 | -6.05 | 472.6445 | 0.683 | 0.94218 | 0.72805 | ||||||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 1 | -5.30 | 298.2392 | 0.073 | 0.94086 | 0.48387 | |||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 2 | -5.36 | 315.9300 | 0.077 | 0.87923 | 0.49275 | |||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 3 | -5.87 | 409.3750 | 0.568 | 0.88750 | 0.68250 | |||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 4 | -5.56 | 395.2990 | 0.163 | 0.92691 | 0.51163 | |||
| HeLa ICRP | Bortezomib | 100 | nM | Apomab | 25.0 | ng/ml | anti-Fc | 25.0 | ng/ml | 5 | -5.44 | 331.4063 | 0.076 | 0.91071 | 0.41295 | |||
| HeLa ICRP FLIP-L-mCherry | TNF10 | 250.0 | ng/ml | 1 | -5.04 | 132.6481 | 0.791 | 0.90941 | 0.73519 | |||||||||
| HeLa ICRP FLIP-L-mCherry | TNF10 | 250.0 | ng/ml | 2 | -4.76 | 97.0362 | 0.796 | 0.86878 | 0.59276 | |||||||||
| HeLa ICRP FLIP-L-mCherry | TNF10 | 250.0 | ng/ml | 3 | -4.85 | 108.6391 | 0.757 | 0.91716 | 0.66272 |